Chromous

Bengaluru, India Founded: 2006 • Age: 20 yrs
Manufacturer of molecular biologicals and molecular biology contract research service provider

About Chromous

Chromous is a Healthcare company based in Bengaluru (India) founded in 2006. It operates as a manufacturer of molecular biologicals and molecular biology contract research service provider. The company has 5 employees. Its Indian entity Chromous Biotech Private Limited reported revenue of β‚Ή34.7 Lakh. Chromous offers products and services including PCR Enzymes, DNA/RNA Isolation Kits, and Restriction Endonucleases. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its competitors include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias and 5 more; 3 of its 10 listed competitors have raised funding.

Company details

Chromous Biotech was established in 2006 and is based in Bengaluru, India. Focus is placed on the molecular biology sector, where enzymes, reagents, and kits for PCR, restriction endonucleases, DNARNA ladders, and associated research areas are produced. Contract research services are extended to support biology studies, alongside teaching kits, small laboratory instruments, and plastic consumables for lab use.

Key Metrics
  • Annual Revenue
    ₹34.7 Lakh

    FY 2024 · -15% YoY

  • Net Loss
    -₹51.6 Lakh

    FY 2024 · -149% margin

  • EBITDA
    -₹50.1 Lakh

    FY 2024 · -145% margin

  • Employee Count
    5

Products & Services of Chromous

Chromous offers a comprehensive portfolio of products and services, including PCR Enzymes, DNA/RNA Isolation Kits, and Restriction Endonucleases.

PCR Enzymes
Enzymes

Enzymes for PCR applications in molecular biology research

DNA/RNA Isolation Kits
Purification Kits

Kits for isolating DNA and RNA from various biological sources

Restriction Endonucleases
Molecular Biology Tools

Enzymes that cut DNA at specific sequences for research

Board of directors of Chromous Biotech Private Limited (Chromous)

Chromous Biotech Private Limited is the primary company behind Chromous. The board of Chromous Biotech Private Limited currently have 2 directors; the longest-serving is Biswajit Roy, appointed in 2006. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Biswajit Roy
DIN 01457468
Managing Director17 Nov 200619 yrs 11 moChromous Biotech Private Limited
Venkita Subbulakshmi
DIN 08124866
Director09 Jul 20188 yrs 3 moChromous Biotech Private Limited

Financials of Chromous

Figures of Chromous Biotech Private Limited, the primary company behind Chromous, for FY 2024. Revenue was ₹34.7 Lakh (-15% year on year). Net loss was -₹51.6 Lakh (-149% margin). EBITDA was -₹50.1 Lakh (-145% margin). Revenue has grown at a compounded annual rate of -71% over three years and -27% over five years.

  • ₹34.7 LakhRevenue · FY 2024 · -15% YoY
  • -₹51.6 LakhNet loss · -149% margin
  • -₹50.1 LakhEBITDA · -145% margin
  • ₹35 LakhPaid-up capital
  • 5Employees (provident fund records)
  • -71%Revenue CAGR, 3 years
  • -27%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Chromous Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for Chromous

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Chromous

Chromous has 10 listed competitors in our database, 3 of them funded. They include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioagilytix.com2008Durham, United States–446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
alderleyanalytical.com2013Stockport, United Kingdom$869,35241
Bioanalytical assays for drug development are developed and validated.
tentamus.com2011Berlin, Germany–368
Analytical and quality assurance services are provided for diverse industries.
nordicbioscience.com1996Herlev, Denmark–178
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
solvias.com1999Kaiseraugst, Switzerland––
Integrated R&D services are provided for pharmaceuticals and allied sectors.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
synexagroup.com2003Cape Town, South Africa––
Provider of comprehensive analytical and advisory services, specializing in biomarker services
eag.com1978San Diego, United States–601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
lightcast.bio2019Cambridge, United Kingdom$107.09M25
Advanced single-cell analysis solutions are provided for biotechnology research.
apocell.com2004Houston, United States–2,198
Provider of clinical trial and clinical development on bioanalytical services
Premium access

Detailed competitors of Chromous

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Chromous (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Chromous

Chromous was founded in 2006.

Chromous is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Chromous has 5 employees.

The primary company behind Chromous, Chromous Biotech Private Limited, reported revenue of β‚Ή34.7 Lakh for FY 2024, down 15% year on year.

Chromous Biotech was established in 2006 and is based in Bengaluru, India. Focus is placed on the molecular biology sector, where enzymes, reagents, and kits for PCR, restriction endonucleases, DNARNA ladders, and associated research areas are produced. Contract research services are extended to support biology studies, alongside teaching kits, small laboratory instruments, and plastic consumables for lab use.

Chromous's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

Chromous offers PCR Enzymes, DNA/RNA Isolation Kits, and Restriction Endonucleases.

Chromous operates through Chromous Biotech Private Limited.

The legal entities of Chromous currently have 2 directors, including Venkita Subbulakshmi, Biswajit Roy.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available